Atlas Trials

A Study of MK-8109 (Vintafolide) Given Alone or With Chemotherapy in Participants With Advanced Cancers (MK-8109-001)

Clinical trial NCT01688791 · TERMINATED

Trial details

NCT number
NCT01688791
Sponsor
Endocyte
Status
TERMINATED
Phase
Phase 1
Study type
INTERVENTIONAL
Advanced Cancer
Start date
2012-12-01
Primary completion
2014-09-01
Enrollment
37

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.